{
  "docId": "019de511-116c-769a-af30-00a56112ffbd",
  "docSlug": "6dbbbde9942752c16f9f4678dff28ed3",
  "documentTitle": "Nyxoah | IPO Presentation Deck | 34 slides",
  "authorId": "nyxoah",
  "authorName": "Nyxoah",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7794254,
  "pageNumber": 16,
  "pageCount": 34,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide highlights Inspire's market advantage as the only FDA-approved device in the US compared to LivaNova's ongoing clinical trials.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-116c-769a-af30-00a56112ffbd/16",
  "deckHref": "/decks/019de511-116c-769a-af30-00a56112ffbd",
  "deckJsonHref": "/decks/019de511-116c-769a-af30-00a56112ffbd.json",
  "deckAnchorHref": "/decks/019de511-116c-769a-af30-00a56112ffbd#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.03,
        "y": 0.88
      },
      "kind": "disclaimer",
      "text": "* Closed-loop = stimulation is synchronized with the breathing pattern / Open-loop = Stimulation is not synchronized with the breathing pattern ** LivaNova Press Release – 15 June 2021 – LINK",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "642c3f76-8af4-46b9-868c-8c28b4e26629",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.15,
        "x": 0.25,
        "y": 0.15
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e5887532-bcd8-42ee-98bf-59b447a2ce6c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.2,
        "x": 0.57,
        "y": 0.18
      },
      "kind": "image",
      "text": "LivaNova Imthera",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74d2cfac-c4e7-4571-a9e3-e5f1af1a8154",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.15,
        "x": 0.03,
        "y": 0.18
      },
      "kind": "image",
      "text": "Inspire",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cfe579cd-ad1e-459b-b5e4-7ab512ee29cf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.35,
        "x": 0.03,
        "y": 0.33
      },
      "kind": "list",
      "text": "Closed-loop neurostimulation device; CE Mark 2010; FDA approval 2014; Only FDA-approved HGNS device in US",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3610ad9a-d313-4bc3-8929-773965188d3e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.35,
        "x": 0.57,
        "y": 0.33
      },
      "kind": "list",
      "text": "Aura6000 open-loop device; CE mark 2012; US IDE study approval 2021 (OSPREY trial)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "874d62f5-c1c7-4943-b3b3-f4fb3c338c86",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "Hypoglossal Nerve Stimulation Competitive Landscape",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "964f0a65-958b-4c93-a334-13f62382ea83",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "22762491-8317-4ba2-89f3-2e095076f204",
      "evidence": "list/bullet: Closed-loop neurostimulation device; CE Mark 2010; FDA approval 2014; Only FDA-approved HGNS device in US",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 16,
      "from": 14,
      "beatId": "a7306455-7242-4685-97b2-b3e5a285001d",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Competition",
      "beatSlug": "sequoia-pitch-competition",
      "evidence": "Slides 14-16 present the competitive landscape and how Genio® System addresses unmet needs",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}